415 related articles for article (PubMed ID: 23294528)
1. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
[TBL] [Abstract][Full Text] [Related]
3. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
[TBL] [Abstract][Full Text] [Related]
4. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.
Kastrup J; Johansen JS; Winkel P; Hansen JF; Hildebrandt P; Jensen GB; Jespersen CM; Kjøller E; Kolmos HJ; Lind I; Nielsen H; Gluud C;
Eur Heart J; 2009 May; 30(9):1066-72. PubMed ID: 19270316
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
[TBL] [Abstract][Full Text] [Related]
6. Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic lesions in stable coronary artery disease.
Peer A; Falkensammer G; Alber H; Kroiss A; Griesmacher A; Ulmer H; Pachinger O; Mair J
Heart; 2009 Feb; 95(4):297-303. PubMed ID: 18708421
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Giannitsis E; Spanuth E; Horsch A; Kleber ME; Koch W; Grammer TB; Koenig W; März W
Clin Chem Lab Med; 2013 Oct; 51(10):2019-28. PubMed ID: 24072576
[TBL] [Abstract][Full Text] [Related]
8. Relationship and prognostic importance of thyroid hormone and N-terminal pro-B-Type natriuretic peptide for patients after acute coronary syndromes: a longitudinal observational study.
Brozaitiene J; Mickuviene N; Podlipskyte A; Burkauskas J; Bunevicius R
BMC Cardiovasc Disord; 2016 Feb; 16():45. PubMed ID: 26892923
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
[TBL] [Abstract][Full Text] [Related]
10. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A
Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781
[TBL] [Abstract][Full Text] [Related]
11. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
12. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
13. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
16. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease.
Mathiasen AB; Harutyunyan MJ; Jørgensen E; Helqvist S; Ripa R; Gøtze JP; Johansen JS; Kastrup J
Scand J Clin Lab Invest; 2011 Sep; 71(5):439-47. PubMed ID: 21827355
[TBL] [Abstract][Full Text] [Related]
17. High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study.
Ivandic BT; Spanuth E; Kleber M; Grammer TB; März W
Clin Chem Lab Med; 2011 Jun; 49(6):1053-8. PubMed ID: 21574877
[TBL] [Abstract][Full Text] [Related]
18. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.
Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A
Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480
[TBL] [Abstract][Full Text] [Related]
19. Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score.
Börekçi A; Gür M; Şeker T; Baykan AO; Özaltun B; Karakoyun S; Karakurt A; Türkoğlu C; Makça I; Çaylı M
Perfusion; 2015 Sep; 30(6):457-64. PubMed ID: 25358476
[TBL] [Abstract][Full Text] [Related]
20. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study.
Erdoğan T; Kocaman SA; Çetin M; Durakoğlugil ME; Kırbaş A; Canga A; Yılmaz A; Doğan S; Çiçek Y
Anadolu Kardiyol Derg; 2013 Aug; 13(5):465-70. PubMed ID: 23728225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]